Percutaneous Closure of Patent Foramen Ovale Sponsors: Kung Ming Jan, M.D., Ph.D. Judah Weinberger, M.D., Ph.D. Columbia University Medical Center Department.

Slides:



Advertisements
Similar presentations
Tutorial June 25 Bio 155. Blood Cellular component: 1)RBC 2)WBC 3)Platelet.
Advertisements

DEVELOPMENT OF ATRIA & VENTRICLES
Congenital Heart Disease Cheston M. Berlin, Jr., M.D. Department of Pediatrics.
Cardiac embryology Karina & Allison.
“PFO Closure: anatomical variants and implications for choice of procedure, success rates and complications” LM Shapiro. Papworth Hospital, Cambridge.
TOPIC 2 Group A.
بسم الله الرحمن الرحيم بسم الله الرحمن الرحيم.
CONGENITAL HEART DISEASE JOHN N. HAMATY D.O. FACC.
Fetal Circulation.
Prepared by: Mrs. Mahdia Samaha Alkony
Amplatzer® Septal Occluder
Disclosure Information Devices for ASD&PFO Closure: Amplatzer Devices As a faculty member for this program, I disclose the following relationships with.
Indications for intervention of ASD and VSD
ZEENAT KHAN 2ND FACULTY OF MEDICINE CHARLES UNIVERSITY CIRCULATION CHANGES AFTER BIRTH Physiology
Congenital Heart Defects. Eight out of every 1,000 infants have some type of structural heart abnormality at birth. Such abnormalities, known as congenital.
Surgical Tools and Equipment
Migraine Intervention with STARFlex Technology (MIST) Trial Presented at The American College of Cardiology Scientific Session 2006 Presented by Dr. Andrew.
FOETAL CIRCULATION. CIRCULATION AFTER BIRTH EMBRYOLOGY Embryologically, the septum primum separates the two atria first, moving inferiorly toward the.
Lecture 56: Development of Heart II. Learning Objectives By the end of this session, the student should be able to: – Describe septum formation in the.
Ostium Secundum Atrial Septal Defect Closure Thomas Hoy Department of Biomedical Engineering BME 272 Senior Design.
Development of Blood Vessels Blood vessel formation (angiogenesis) starts at the beginning of the third week. Blood vessels first start to develop in the.
INTRODUCTION A 35 year old woman with transposition of the great arteries repaired with a Mustard procedure attends your clinic for annual follow-up. Her.
PFO Dr Peter Wilmshurst Royal Shrewsbury Hospital Co-workers: Simon Nightingale, Lindsay Morrison, Matthew Pearson, Kevin Walsh, Phil Bryson, John Davis,
CASE 2 Group B. Baby Fiona Goodchild was born on May 3, It was noted that she had a low birth weight of 2600g. Normally, the average weight of a.
Cardiovascular Development. The first three weeks By the beginning of the third week, blood vessel formation begins in the tissue surrounding the yolk.
CONGENITAL HEART DISEASE JOHN N. HAMATY D.O. FACC.
- Describe the clinical features that point to the presence of a congenital heart malformation. - Describe the general classification of heart diseases.
Development of cardiovascular system.
Vanessa Beretta & Dan Fleming. About CHD A congenital heart defect also known as CHD is a defect in the structure of the heart and great vessels. Most.
Atrial septal defects David M. Chaky, MD. Terminology ► ASD = defect in the atrial septum of the heart which can be isolated anomaly or associated with.
Ostium Secundum Atrial Septal Defect Closure Thomas Hoy February 11, 2004 Department of Biomedical Engineering BME 272 Senior Design.
Congenital Heart Disease Most occur during weeks 3 to 8 Incidence 6 to 8 per 1,000 live born births Some genetic – Trisomies 13, 15, 18, & 21 and Turner.
By Prof. Saeed Abuel Makarem. Objectives By the end of the lecture you should be able to: Describe the formation, site, union, division of the of the.
Congenital Heart Lesions
Cardiovascular surgery, Congenital heart disease Dr. Robin Man Karmacharya, Lecturer, Department of Surgery, Dhulikhel Hospital.
Transcatheter ASD closure, sans X-rays Peter Ewert MD Robert Beekman MD.
Fetal Circulation Mike Clark, M.D.. Figure (a) Day 20: Endothelial tubes begin to fuse. (b) Day 22: Heart starts pumping. (c) Day 24: Heart continues.
UBC-Case 1 Samuel Yip PhD, MD, FRCPC Western Stroke Day 2012.
DHHS / FDA / CDRH 1 FDA Summary CardioSEAL® STARFlex™ Septal Occlusion System with Qwik Load NMT Medical P000049/S3.
C E N T E R F O R C O N G E N I T A L H E A R T D I S E A S E S T U T T G A R T Presenter disclosure information name: Frank Uhlemann In the last 12 month.
DR AFTAB YUNUS FRCSEd. CHAIRMAN CARDIAC SURGERY
Development of the Heart and Congenital Heart diseases SESSION 6.
DR RANIA GABR.  Discuss the congenital anomalies related to the heart development.
By M.elkhatib.  Equal  R = L  Q refers to flow  Therefore Qp = Qs  Blood flow to both the pulmonary & systemic circulations is balanced.  Homeostasis.
Ostium Secundum Atrial Septal Defect Closure Thomas Hoy April 14, 2004 Department of Biomedical Engineering BME 273 Senior Design.
Antithrombotic and Thrombolytic Therapy for Valvular Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
H. Amoozgar, MD Professor of pediatric cardiology Shiraz University of Medical Sciences, Shiraz, Iran TRANSCATHETER CLOSURE OF LARGE CORONARY-CAMERAL FISTULAE.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Closure of Atrial Septal Defects With the Amplatzer.
Patent Ductus Arteriosus Occlusion Device Christina Mathieson Trung Nguyen Advisor: Dr. Tom Doyle BME 273 – Senior Design Project.
Atrial Septal Defect R3 이재연.
Antithrombotic and Thrombolytic Therapy for Valvular Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest.
Prof. Dr. med. H. R. Figulla Director at the University Hospital Jena
Dr. M. A. Sofi MD; FRCP (London); FRCPEdin; FRCSEdin
Update on PFO stents Mark Reisman, M.D., F.A.C.C.
Successful retrieval of embolized atrial septal defect and patent foramen ovale closure device using novel coronary wire trap (CWT) technique. Alireza.
DEVICE FOR THE IMPLANTATION OF NEURAL ELECTRODE ARRAYS
Double Circulation.
Percutaneous Closure of a Coronary Fistula
2 A Cardiology Department, University of Athens
CONGENITAL HEART DISEASES II
Incidence of May-Thurner Syndrome in Patients undergoing Patent Foramen Ovale Closure for Cryptogenic Stroke Thomas J. Kiernan MD, Bryan P Yan MD, Pablo.
Patent Ductus Arteriosus Occlusion Device
Patent Foramen Ovale and Stroke
Osami Honjo, MD, PhD, Vivek Rao, MD 
Three-dimensional echo-guided beating heart surgery without cardiopulmonary bypass: Atrial septal defect closure in a swine model  Yoshihiro Suematsu,
Subramaniam C. Krishnan, and Miguel Salazar JCIN 2010;3:98-104
From Benchtop to Bedside
Sagit Ben Zekry et al. JIMG 2008;1:
Development of Blood Vessels
Endoluminal Closure Device
Presentation transcript:

Percutaneous Closure of Patent Foramen Ovale Sponsors: Kung Ming Jan, M.D., Ph.D. Judah Weinberger, M.D., Ph.D. Columbia University Medical Center Department of Cardiology Project TA: Jeffrey Garanich, Ph.D. Design Team: Ali Stern Dmitry Oulianov Dolores Miranda Henry Qazi Safiya Arif The City College of New York / Department of Biomedical Engineering

Prenatal oxygenation of blood bypasses lungs. Prenatal oxygenation of blood bypasses lungs. Oxygenated blood passes from right to left atrium through the foramen ovale (FO). Oxygenated blood passes from right to left atrium through the foramen ovale (FO). Fetal circulation Fetal Circulation

Septum primum and secundum overlap. Septa create an opening to allow direct shunting of fetal blood. Prenatal Septal Development

Following birth the P of each chamber changes. Following birth the P of each chamber changes. P changes force septum primum to close over septum secundum. P changes force septum primum to close over septum secundum. In a period of 1-2 weeks 70% of population have fusion of septa primum and secundum. In a period of 1-2 weeks 70% of population have fusion of septa primum and secundum. Neonatal Septal Development

The condition in which the septa fail to seal over and remain patent is known as ASD. The condition in which the septa fail to seal over and remain patent is known as ASD. ASD is an opening (hole) between right and left atria. ASD is an opening (hole) between right and left atria. Atrial Septal Defect

Patent Foramen Ovale PFO, a type of ASD, is a flap- like opening between the atrial septa primum and secundum PFO, a type of ASD, is a flap- like opening between the atrial septa primum and secundum

Clinical Need PFO is present in 20-25% of the population PFO is present in 20-25% of the population PFO has been associated with: PFO has been associated with: Migraines Cryptogenic strokes Systemic embolism

Migraine is a vascular headache Migraine is a vascular headache Over 2,500,000 people in the U.S. have at least one migraine weekly, with a lifetime prevalence of 18% Over 2,500,000 people in the U.S. have at least one migraine weekly, with a lifetime prevalence of 18% PFO are related to Migraines if paradoxic embolism causes headache PFO are related to Migraines if paradoxic embolism causes headache Migraine

Cryptogenic strokes There are 700,000 strokes per year in the U.S. There are 700,000 strokes per year in the U.S % of these are cryptogenic 30-40% of these are cryptogenic 40-70% of cryptogenic strokes are PFO related 40-70% of cryptogenic strokes are PFO related 84, ,000 strokes per year in the United States are by paradoxical embolism due to PFO 84, ,000 strokes per year in the United States are by paradoxical embolism due to PFO

Treatment Options Medical Treatment Medical Treatment Open heart surgery to close the PFO Open heart surgery to close the PFO Percuteneous closure of the PFO Percuteneous closure of the PFO

CardioSeal 2 Double Umbrella implant 2 Double Umbrella implant MP35N Framework MP35N Framework Dacron Dacron Sizes: 17-33mm Sizes: 17-33mm

Amplazter Self expandable Self expandable Short connecting waist Short connecting waist Nitinol Wires Nitinol Wires Sizes: 4-38mm Sizes: 4-38mm

Amplazter Delivery

Disadvantages Designed for ASD Designed for ASD Large surface Area Large surface Area Thrombus formation Thrombus formation Reduced Endothelialization Reduced Endothelialization Poor Apposition Poor Apposition Device Fracture Device Fracture Device Embolization Device Embolization

 Seals PFO only  Consists of two components  Delivery unit  Means of closure  Size requirements  Delivery size: mm diameter  Deployment size: 3.6 x 4.2 cm  Seals area of 8 mm radius around PFO  Biocompatibility  Immunological response  Thrombogenic response  Single use Required Specifications

 Electrical isolation  Isolate main voltage source  Prevent current leakage  Current limits  Direct current < 1 μA  Alternating current < 0.4 μA  Mechanical forces  Structural flexibility Mechanical & Electrical Stability

 Easily operable  Cost efficient  Biodegradable  Degradation time  Particle size  Visible by ultrasound  Non-magnetic Desired Specifications

 In Vitro  Reaction to environment  Fatigue test  Maneuverability  Catheter-device integrity  In Vivo*  Dog testing  Human testing *Evaluation may not be performed in the scope of the project Device Evaluation

Concepts Glue or collagen plugs Glue or collagen plugs Magnetic suturing Magnetic suturing Energy welding devices Energy welding devices Staple pins/sutures Staple pins/sutures Scaffold Scaffold Clipping device Clipping device Intra atrium device Intra atrium device Coiled suturing device Coiled suturing device “Sutura” model “Sutura” model

Hooked Scaffold Implant Polyester scaffold Polyester scaffold Advantages: Advantages: Material Degradation into H2O & CO2 Material Degradation into H2O & CO2 Disadvantages : Disadvantages : Material: too stiff for delivery Material: too stiff for delivery

Intra atrium device (IAD) Advantages: Advantages: Minimal amount of foreign material in the body Minimal amount of foreign material in the body Does not require exact positioning Does not require exact positioning Disadvantages: Disadvantages: Material selection: Complicated knot delivery method

Coiled needle Components: coiled needle, 16mm base unit Components: coiled needle, 16mm base unit Advantages: Advantages: Does not require exact positioning Does not require exact positioning Disadvantages: Disadvantages: Complicated mechanics Complicated mechanics Requires electrical energy Requires electrical energy Complicated knot delivery method Complicated knot delivery method

Sutura Model Suturing device Suturing device Components: 2 retractable arms, thread attached, 2 needles, handle Components: 2 retractable arms, thread attached, 2 needles, handle Advantages: Advantages: Existing device provides successful mechanism Existing device provides successful mechanism Disadvantages: Disadvantages: Complicated manufacturing Complicated manufacturing

Clipping Device Advantages: Advantages: Procedure using the device is reversible in case of failure Simple deployment mechanism Disadvantages: Disadvantages: Requires precision Material properties

Acknowledgements Kung Ming Jan, M.D., Ph.D. Kung Ming Jan, M.D., Ph.D. Judah Weinberger, M.D., Ph.D. Judah Weinberger, M.D., Ph.D. Columbia University Medical Center Columbia University Medical Center Department of Cardiology Department of Cardiology Project TA: Jeffrey Garanich, Ph.D. Project TA: Jeffrey Garanich, Ph.D. Robert Sommer, M.D., Ph.D. Robert Sommer, M.D., Ph.D.